European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like How good gut bacteria help reduce the risk for heart disease July 14, 2020 In Vitro Modification of Psyllium Viscosity Impacts Gas Production February 24, 2023 New Study Demonstrates Consistent and Targeted Prebiotic Effects of Benicaros® August 7, 2025